Acne vulgaris

Nivel de evidencia C
Estudios de observación (cohortes) de mala calidad o ensayos controlados aleatorizados con metodología defectuosa (RCT) de <200 participantes.

Reduction in number of inflammatory lesions in mild to severe acne: there is poor-quality evidence that, compared with placebo or vehicle agent, topical clindamycin 1% reduced the number of inflammatory lesions at 8 to 12 weeks.

Más información de BMJ Clinical Evidence

Use of this content is subject to our disclaimer